Effect of plant sterols on the lipid profile of patients with hypercholesterolaemia. Randomised, experimental study

Ignacio Párraga, Jesús López-Torres, Fernando Andrés, Beatriz Navarro, José M del Campo, Mercedes García-Reyes, María P Galdón, Angeles Lloret, Juan C Precioso, Joseba Rabanales, Ignacio Párraga, Jesús López-Torres, Fernando Andrés, Beatriz Navarro, José M del Campo, Mercedes García-Reyes, María P Galdón, Angeles Lloret, Juan C Precioso, Joseba Rabanales

Abstract

Background: Studies have been conducted on supplementing the daily diet with plant sterol ester-enriched milk derivatives in order to reduce LDL-cholesterol levels and, consequently, cardiovascular risk. However, clinical practice guidelines on hypercholesterolaemia state that there is not sufficient evidence to recommend their use in subjects with hypercholesterolaemia. The main objective of this study is to determine the efficacy of the intake of 2 g of plant sterol esters a day in lowering LDL-cholesterol levels in patients diagnosed with hypercholesterolaemia. The specific objectives are: 1) to quantify the efficacy of the daily intake of plant sterol esters in lowering LDL-cholesterol, total cholesterol and cardiovascular risk in patients with hypercholesterolaemia; 2) to evaluate the occurrence of adverse effects of the daily intake of plant sterol esters; 3) to identify the factors that determine a greater reduction in lipid levels in subjects receiving plant sterol ester supplements.

Methods/design: Randomised, double-blind, placebo controlled experimental trial carried out at family doctors' surgeries at three health centres in the Health Area of Albacete (Spain). The study subjects will be adults diagnosed with "limit" or "defined" hypercholesterolaemia and who have LDL cholesterol levels of 130 mg/dl or over. A dairy product in the form of liquid yoghurt containing 2 g of plant sterol ester per container will be administered daily after the main meal, for a period of 24 months. The control group will receive a daily unit of yogurt not supplemented with plant sterol esters that has a similar appearance to the enriched yoghurt. The primary variable is the change in lipid profile at 1, 3, 6, 12, 18 and 24 months. The secondary variables are: change in cardiovascular risk, adherence to the dairy product, adverse effects, adherence to dietary recommendations, frequency of food consumption, basic physical examination data, health problems, lipid-lowering medication, physical activity, smoking habits and socio-demographic variables.

Discussion: If plant sterol ester supplements were effective a sounder recommendation for the consumption of plant sterols in subjects with hypercholesterolaemia could be made.

Trial registration: ClinicalTrials.gov NCT01406106.

Figures

Figure 1
Figure 1
Study's flowchart outlining.

References

    1. Instituto Nacional de Estadística of Spain. Defunciones por causa de muerte. Boletín Mensual Estadística; 2006. p. 172. INE; c2006. Available from: 2009. .
    1. Medrano MJ, Cerrato E, Boix R, Delgado-Rodriguez M. Cardiovascular risk in Spanish population: metaanalysis of cross-sectional studies. Med Clin (Bar) 2005;124:606–612. doi: 10.1157/13074389.
    1. Gutiérrez Fuentes JA, Gómez Gerique JA, Gómez de la Cámara A, Rubio MA, García Hernández A, Arístegui I. Diet and Cardiovascular Risk in Spain Study (DRECE II). Description of the evolution of cardiovascular profile. Med Clin (Barc) 2000;115:726–729.
    1. Villar Álvarez F, Banegas JR, Donado Campos JM, Rodríguez Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2003. Madrid: Ergon; 2003.
    1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367–72.
    1. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ. 2002;324:1570–6. doi: 10.1136/bmj.324.7353.1570.
    1. Keys A. Coronary heart disease, serum cholesterol, and the diet. Acta Med Scand. 1980;207:153–60.
    1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, simes R. Cholesterol Treatment Trialist' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–78.
    1. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, Spiegelman D, Hunter DJ, Colditz GA, Willett WC. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76:1261–1271.
    1. Sudhop T, Von Bergman K. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. 2002. pp. 2333–47.
    1. Jenkins DJA, Kendall CWC, Marchie A, Faulkner DA, Wong JMW, De Souza R, Emam A, Parker TL, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W, Conelly PW. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterlemic participants. Am J Clin Nutr. 2005;81:380–387.
    1. Bellisle F, Diplock AT, Hornstra G, Koletzko B, Roberfroid M, Salminen S, Saris WHM. Functional food science in Europe. Br J Nutr. 1998;80:173–193. doi: 10.1079/BJN19980109.
    1. Milner JA, Craig L. Physiologically active food components: their role in optimizing health and aging. Am J Clin Nutr. 2000;71:1653–1743.
    1. Ross E. Introduction to functional food. Med Clin (Bar) 2001;116:617–9.
    1. Silveira MB, Monereo S, Molina B. Funtional nutrition and optimal nutricion. Near or far? Rev Esp Salud Pública. 2003;77(3):317–331.
    1. Plaza I. Los fitosteroles, el colesterol y la prevención de las enfermedades cardiovasculares. Clin Invest Arterioesclerosis. 2001;5:209–18.
    1. Piironen V, Lindsay DG, Miettinen TA, Toivo J, Lampi AM. Plant sterols: biosynthesis: biological function and their importance to human nutrition. J Sci Food Agric. 2000;80:939–966. doi: 10.1002/(SICI)1097-0010(20000515)80:7<939::AID-JSFA644>;2-C.
    1. Heinemann T, Kullabak-Ublick A, Pietruck B, von Bergmann K. Mechanism of action of plant sterols on inhbition of cholesterol absorption. Eur J Clin Pharmacol. 1991;20:59–63.
    1. Cater NB. Plant Stanol Ester: Review of cholesterol-lowering efficacy and implications for coronary heart disease risk reduction. Prev Cardiol. 2000;3:121–30. doi: 10.1111/j.1520-037X.2000.80370.x.
    1. Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. Plant stanol esters affect serum cholesterol concentrations of hypercholesteroemic men and women in a dose-dependent manner. J Nutr. 2000;130:767–776.
    1. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308–1312. doi: 10.1056/NEJM199511163332002.
    1. Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H. Serum, biliary and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr. 2000;71:1095–1102.
    1. Noakes M, Clifton PM, Doornbos AM, Trautwein EA. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Nutr. 2005;44:214–222. doi: 10.1007/s00394-004-0513-z.
    1. Blari SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, cater NB. Incremental reduction in total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86:46–52.
    1. Nigon F, Serfaty L, Beucler I, Chauvois D, Neveu C, Giral P, Chapman MJ, Bruckert E. Plant sterol-enriched margarine lowers plasma LDL in hyperlipidaemia subjects with low cholesterol intake: effect of fibrate treatment. Clin Chem Lab Med. 2001;39:634–640. doi: 10.1515/CCLM.2001.103.
    1. Gylling H, Miettinen TA. Combination therapy with statins. Curr Opin Investig Drugs. 2002;3:1318–23.
    1. Katan MB, Grundy SM, Jones P, Law M, Miettinen TA, Paoletti R. Stresa Workshop Participants. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965–978. doi: 10.4065/78.8.965.
    1. Law M. Plant sterol and stanol margarines and health. Br Med J. 2000;320:861–864. doi: 10.1136/bmj.320.7238.861.
    1. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis. 2002;160:205–213. doi: 10.1016/S0021-9150(01)00562-7.
    1. O'Neill FH, Brynes A, Mandeno R, Rendell N, Taylor G, Seed M, Thompson GR. Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis. 2004;14:133–142. doi: 10.1016/S0939-4753(04)80033-4.
    1. Mattson FH, Grundy SM, Crouse JR. Optimizing the effect of plant sterols on cholesterol absorption in man. Am J Clin Nutr. 1982;35:697–700.
    1. Plat J, van Onselen EN, van Heugten MM, Mensink RP. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr. 2000;54:671–677. doi: 10.1038/sj.ejcn.1601071.
    1. Expert Panel on Detection; Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) National Cholesterol Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NECEP) JAMA. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486.
    1. Van Horn L, Ernst N. A summary of the science supporting the new National cholesterol Education Program dietary recommendations: What dietitians should know. J Am Diet Ass. 2001;101:1148–54. doi: 10.1016/S0002-8223(01)00283-8.
    1. Lichtenstein AH, Deckelbaum RJ. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation. 2001;103:1177–9.
    1. American Heart Association Nutrition Committee. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96. doi: 10.1161/CIRCULATIONAHA.106.176158.
    1. Algorta J, Chinchetru MJ, Aguirre J, Francisco S. Hypocholesteremic effectiveness of a yogurt containing plant stanol esters. Rev Clin Esp. 2005;205:63–66. doi: 10.1157/13072497.
    1. Slesinski RS, Turnbull DV, Frankos VH, Wolterbeek AP, Waalkens-Berendsen DH. Developmental toxicity study of vegetable oil-derived stanol fatty acid esters. Regul Toxicol Pharmacol. 1999;29:227–233. doi: 10.1006/rtph.1999.1292.
    1. De Jong N, Pijpers L, Bleeker JK, Ocke MC. Potential intake of phytosterols/-stanols: results of a simulation study. Eur J Clin Nutr. 2004;58:907–919. doi: 10.1038/sj.ejcn.1601912.
    1. Brufau G, Canela MA, Rafecas M. Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties. Nutrition Research. 2008;28:217–225. doi: 10.1016/j.nutres.2008.02.003.
    1. Moruisi KG, Oosthuizen W, Opperman AM. Phytosterols/Stanols Lower Cholesterol Concentrations in Familial Hypercholesterolemic Subjects: A Systematic Review with Meta-Analysis. J Am Coll Nutr. 2006;25:41–48.
    1. Jordan S, Griffiths J, Pilon K. Sterol and sterolin-containing products: hematologic adverse reactions. CMAJ. 2004;170:1347–8. 1351-2.
    1. Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. Effect of low-fat stanol enriched margarine on concentrations of serum carotenoids in subjects with elevated serum cholesterol concentrations. Eur J Clin Nutr. 1999;53:966–969. doi: 10.1038/sj.ejcn.1600882.
    1. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. The American journal of clinical nutrition. 2002;75:79–86.
    1. Commision Decission on authorising the placing on the market of yellow fat spreads with added phytosterols esters as a novel food or novel food ingredient under regulation (EC) No 258/97 of the European Parliament and of the Council. Official Journal of the European Communities. 2000;2121 200/59-60.
    1. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol. 2000;35:1185–1191. doi: 10.1016/S0735-1097(00)00527-1.
    1. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a Nested Case-Control Analysis of the prospective Cardiovascular Munster (PROCAM) Study. Nutr Metab Cardiovasc Dis. 2006;16:13–21. doi: 10.1016/j.numecd.2005.04.001.
    1. Moghadasian MH, McManus BM, Godin DV, Rodrigues B, Frohlich JJ. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice. Possible mechanisms of action. Circulation. 1999;99:1733–1739.
    1. Volger OL, Mensink RP, Plat J, Honstra G, Havekes LM, Princen HM. Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in ApoE 3-Leiden transgenic mice. Atherosclerosis. 2001;157:375–381. doi: 10.1016/S0021-9150(00)00750-4.
    1. Ratnayake WM, l'Abbe MR, Mueller R, Hayward S, Plouffe L, Hollywood R, trick K. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr. 2000;130:1166–1178.
    1. Child P, Kuksis A. Differential uptake of cholesterol and plant sterols by rat erythrocytes in vitro. Lipids. 1982;17:748–754. doi: 10.1007/BF02534662.
    1. De Jong A, Plat J, Mensink RP. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment. Eur J Clin Nutr. 2006;60:985–990. doi: 10.1038/sj.ejcn.1602409.
    1. Hendriks HFJ, Brink EJ, Meijer GW, Princen HMG, Ntanios FY. Safety of long-term consumption of plant sterol ester-enriched spread. Eur J Clin Nutr. 2003;57:681–692. doi: 10.1038/sj.ejcn.1601598.
    1. Grundy SM. Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report. Am J Cardiol. 2001;96:47–50.
    1. National Institute of Health and Clinical Excellence. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. NICE; 2008. (Clinical guideline 71.) Availble from: 2009

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する